Viewing Study NCT00840606


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2025-12-26 @ 11:00 AM
Study NCT ID: NCT00840606
Status: COMPLETED
Last Update Posted: 2024-08-19
First Post: 2009-02-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Buspirone Hydrochloride 30mg Tablets, Fasting
Sponsor: Teva Pharmaceuticals USA
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module